Golden Throat successfully coughs up $108m IPO

The Chinese throat lozenges maker overcame turbulent markets to complete its Hong Kong IPO after trading in a quarter of A-share-listed companies was suspended.

Golden Throat successfully coughs up $108m IPO

Chinese lozenges maker Golden Throat overcame testing market conditions on Tuesday to successfully price its initial public offering in Hong Kong, albeit near the bottom of its indicative range as Chinese share worries continued to swirl.

Beijing suspended new share sales over the weekend in a bid to stabilise the country’s stock markets, after these fell almost 30% in three weeks. Some 760 companies more than a quarter of all...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: credit suisse | golden throat | ipo | hong kong

Print Edition

FinanceAsia Print Edition